How extensive is Sepracors pipeline?
Sepracor has several compounds in early stages of development. Sepracor’s drug development pipeline includes drug candidates SEP-225289 for the treatment of major depressive disorder, SEP-227162 for the treatment of depression and SEP-225441 as a potential treatment for generalized anxiety disorder and panic disorder, as well as several additional targets in preclinical trials. Click here to learn more about our pipeline.